Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial
Nutrients · 09.06.2023 · 15 (12) · 2682
DOI: 10.3390/nu15122682 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 09.06.2023. Verfasst von Nicholas Angelopoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Unit, Athens Medical Centre, 65403 Athens, Greece. Hauptthemen laut MEDLINE: Hypercholesterolemia, Olea, Vitis, Dyslipidemias. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Certain nutraceuticals, mainly containing red yeast rice, might be considered as an alternative therapy to statins in patients with dyslipidemia, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. The aim of this study was to assess the lipid-lowering activity and safety of a dietary supplement containing a low dose of monacolin K combined with coenzyme Q10, grape seed and olive tree leaf extracts in patients with mild hypercholesterolemia. In total, 105 subjects with mild hypercholesterolemia (low-density lipoprotein cholesterol LDL-C levels 140–180 mg/dL) and low CV risk were randomly assigned into three treatment groups: lifestyle modification (LM), LM plus a low dosage of monacolin K (3 mg), and LM plus a high dosage of monacolin K (10 mg) and treated for 8 weeks. The primary endpoint was the reduction of LDL-C and total cholesterol (TC). LDL-C decreased by 26.46% on average (p < 0.001) during treatment with 10 mg of monacolin and by 16.77% on average during treatment with 3 mg of monacolin (p < 0.001). We observed a slight but significant reduction of the triglyceride levels only in the high-dose-treated group (mean −4.25%; 95% CI of mean −11.11 to 2.61). No severe adverse events occurred during the study. Our results confirm the LDL-C-lowering properties of monacolin are clinically meaningful even in lower doses of 3 mg/day.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Unit, Athens Medical Centre, 65403 Athens, Greece.
- Private Practice, Venizelou Str., 65302 Kavala, Greece.
- Center for Diabetes and Endocrine Research, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USA.
- Private Practice, Gerokostopoulou 24, 26221 Patra, Greece.
- Private Practice, Tzanaki Emmanouil 17, 73134 Chania, Greece.
ORCID-Profile: Nicholas Angelopoulos, Rodis D Paparodis, Anastasios Boniakos, Georgia Argyrakopoulou
Zitieren
APA
Angelopoulos, N., Paparodis, R. D., Androulakis, I., Boniakos, A., Argyrakopoulou, G., & Livadas, S. (2023). Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial. Nutrients, 15(12), 2682. https://doi.org/10.3390/nu15122682
Vancouver
Angelopoulos N, Paparodis RD, Androulakis I, Boniakos A, Argyrakopoulou G, Livadas S. Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial. Nutrients. 2023;15(12):2682. doi:10.3390/nu15122682
BibTeX
@article{Angelopoulos2023,
author = {Angelopoulos, Nicholas and Paparodis, Rodis D and Androulakis, Ioannis and Boniakos, Anastasios and Argyrakopoulou, Georgia and Livadas, Sarantis},
title = {Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {12},
pages = {2682},
doi = {10.3390/nu15122682}
}
EUVIMED